EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS145-12214 
Organism
Homo sapiens 
Tissue/cell
NHBE 
Coordinate
chr2:20435530-20437520 
SNPs
Number: 1             
IDChromosomePositionGenome Version
rs72785217chr220437384hg19
TF binding sites/motifs
Number: 52             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr2:20436256-20436274CCTTCCTTCCCACCCTTC-6.03
EWSR1-FLI1MA0149.1chr2:20436268-20436286CCCTTCTTCCCTCCCTCC-6.04
EWSR1-FLI1MA0149.1chr2:20436272-20436290TCTTCCCTCCCTCCCTCC-6.16
EWSR1-FLI1MA0149.1chr2:20436244-20436262CTTCCTTCCCTTCCTTCC-6.1
EWSR1-FLI1MA0149.1chr2:20436199-20436217CTTTCCTTCTTTCCTCTC-6.24
EWSR1-FLI1MA0149.1chr2:20436308-20436326TACTTCTTCCTTCCTTCC-6.32
EWSR1-FLI1MA0149.1chr2:20436243-20436261CCTTCCTTCCCTTCCTTC-6.33
EWSR1-FLI1MA0149.1chr2:20436183-20436201CCTTTCTTCTTTCCTTCT-6.47
EWSR1-FLI1MA0149.1chr2:20436175-20436193CCTTTCTTCCTTTCTTCT-6.64
EWSR1-FLI1MA0149.1chr2:20436219-20436237CCTCCCTTCCTTCCCACC-6.6
EWSR1-FLI1MA0149.1chr2:20436227-20436245CCTTCCCACCCTCCTTCC-6.78
EWSR1-FLI1MA0149.1chr2:20436281-20436299CCTCCCTCCCTTCCTCCC-6.92
EWSR1-FLI1MA0149.1chr2:20436223-20436241CCTTCCTTCCCACCCTCC-6.94
EWSR1-FLI1MA0149.1chr2:20436191-20436209CTTTCCTTCTTTCCTTCT-6.95
EWSR1-FLI1MA0149.1chr2:20436187-20436205TCTTCTTTCCTTCTTTCC-6.96
EWSR1-FLI1MA0149.1chr2:20436231-20436249CCCACCCTCCTTCCTTCC-7.03
EWSR1-FLI1MA0149.1chr2:20436277-20436295CCTCCCTCCCTCCCTTCC-7.08
EWSR1-FLI1MA0149.1chr2:20436171-20436189TCTTCCTTTCTTCCTTTC-7.18
EWSR1-FLI1MA0149.1chr2:20436215-20436233TCTCCCTCCCTTCCTTCC-7.25
EWSR1-FLI1MA0149.1chr2:20436293-20436311CCTCCCTTCCTTCCTTAC-7.82
EWSR1-FLI1MA0149.1chr2:20436195-20436213CCTTCTTTCCTTCTTTCC-7.85
EWSR1-FLI1MA0149.1chr2:20436252-20436270CCTTCCTTCCTTCCCACC-7.87
EWSR1-FLI1MA0149.1chr2:20436297-20436315CCTTCCTTCCTTACTTCT-7.88
EWSR1-FLI1MA0149.1chr2:20436179-20436197TCTTCCTTTCTTCTTTCC-7
EWSR1-FLI1MA0149.1chr2:20436285-20436303CCTCCCTTCCTCCCTTCC-8.06
EWSR1-FLI1MA0149.1chr2:20436239-20436257CCTTCCTTCCTTCCCTTC-8.32
EWSR1-FLI1MA0149.1chr2:20436312-20436330TCTTCCTTCCTTCCCTCC-8.52
EWSR1-FLI1MA0149.1chr2:20436248-20436266CTTCCCTTCCTTCCTTCC-8.57
EWSR1-FLI1MA0149.1chr2:20436320-20436338CCTTCCCTCCTTCCTTCC-9.09
EWSR1-FLI1MA0149.1chr2:20436235-20436253CCCTCCTTCCTTCCTTCC-9.72
EWSR1-FLI1MA0149.1chr2:20436289-20436307CCTTCCTCCCTTCCTTCC-9.83
EWSR1-FLI1MA0149.1chr2:20436316-20436334CCTTCCTTCCCTCCTTCC-9.93
MEF2CMA0497.1chr2:20437232-20437247TTCTATTTTTAATTT-6.12
TFAP2CMA0524.2chr2:20435652-20435664TGCCCTGGGGCA+6.44
TFAP2CMA0524.2chr2:20435652-20435664TGCCCTGGGGCA-7.22
ZNF263MA0528.1chr2:20436202-20436223TCCTTCTTTCCTCTCTCCCTC-6.12
ZNF263MA0528.1chr2:20436227-20436248CCTTCCCACCCTCCTTCCTTC-6.16
ZNF263MA0528.1chr2:20436206-20436227TCTTTCCTCTCTCCCTCCCTT-6.18
ZNF263MA0528.1chr2:20436244-20436265CTTCCTTCCCTTCCTTCCTTC-6.24
ZNF263MA0528.1chr2:20436289-20436310CCTTCCTCCCTTCCTTCCTTA-6.32
ZNF263MA0528.1chr2:20436240-20436261CTTCCTTCCTTCCCTTCCTTC-6.39
ZNF263MA0528.1chr2:20436276-20436297CCCTCCCTCCCTCCCTTCCTC-6.54
ZNF263MA0528.1chr2:20436256-20436277CCTTCCTTCCCACCCTTCTTC-6.61
ZNF263MA0528.1chr2:20436211-20436232CCTCTCTCCCTCCCTTCCTTC-6.67
ZNF263MA0528.1chr2:20436272-20436293TCTTCCCTCCCTCCCTCCCTT-6.85
ZNF263MA0528.1chr2:20436285-20436306CCTCCCTTCCTCCCTTCCTTC-6.93
ZNF263MA0528.1chr2:20436280-20436301CCCTCCCTCCCTTCCTCCCTT-7.27
ZNF263MA0528.1chr2:20436268-20436289CCCTTCTTCCCTCCCTCCCTC-7.49
ZNF263MA0528.1chr2:20436316-20436337CCTTCCTTCCCTCCTTCCTTC-7.58
ZNF263MA0528.1chr2:20436277-20436298CCTCCCTCCCTCCCTTCCTCC-7.9
ZNF263MA0528.1chr2:20436223-20436244CCTTCCTTCCCACCCTCCTTC-8.06
ZNF263MA0528.1chr2:20436312-20436333TCTTCCTTCCTTCCCTCCTTC-8.24
Number of super-enhancer constituents: 10             
IDCoordinateTissue/cell
SE_02914chr2:20435910-20436272Bladder
SE_23108chr2:20435429-20436301Colon_Crypt_1
SE_23761chr2:20435435-20436241Colon_Crypt_2
SE_24805chr2:20435425-20436239Colon_Crypt_3
SE_26530chr2:20435190-20437204Esophagus
SE_35878chr2:20430227-20437683HMEC
SE_50296chr2:20435375-20436284Sigmoid_Colon
SE_56896chr2:20435280-20436289VACO_400
SE_56896chr2:20436326-20436840VACO_400
SE_64257chr2:20435164-20437609NHEK
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr22043643820436799
chr22043578020436055
Number: 1             
IDChromosomeStartEnd
GH02I020230chr22043036820437558
Enhancer Sequence
ACCACTGCTA CATTGCTCTC CCCAAACGCT GTGTCTCCAT GGTCCTTTGG ATGCTCTTAA 60
ATTGCAGCGA GCGCCCACTC CCAGCCAGGG CCTGGGGGTG CATGCTGTCC AAGGCAGGGC 120
CCTGCCCTGG GGCAACTGCA ATCTTTGAGT CCTATGATGA GATGGTTCAA GAGCCAGGGG 180
CCCCAGTCCT GGGTTGCAGG GAGGAGTTCA GGGAAGGCTT CCTGGAGGAG TTGACGTCCA 240
GGCAGAAACC TGCCTGCTGA GTAGCAGTTT GTCAGGCAGG GGAGCAAGTG GGCAGGGCTG 300
CTCAAGCTAG GGGAGGACTT GGCCAGCTGA GGCCCTGAAA GGGCCAGGGC CATCTACGCA 360
CCGCTGAGTA ATGGTGTTCC CTAAATGCTC AGGGCAGTGG CTGAAGGGAG TGGCAGTGGG 420
TGGGGATGAC AGGAAGCTGG GGCAACCGGT GAAGGCCTTC ACTGCCAAGC TAAGGAGTGG 480
GAATGTTGCC CAGGGCAAGC GAGAGCCTGA TTACACACCT GAGGAAGTGA GCCATAGGCT 540
GGAGGGGAGA AAGGACCAGT GCCCTGGGAT GGAGGCTGGG TGGGAATTCA CACCTGGCAA 600
GAGCCCACCA GGAGCCAGGC CCTGTGTAAG GAGAAGCCCC CTCTTCCTTT CTTCCTTTCT 660
TCTTTCCTTC TTTCCTTCTT TCCTCTCTCC CTCCCTTCCT TCCCACCCTC CTTCCTTCCT 720
TCCCTTCCTT CCTTCCCACC CTTCTTCCCT CCCTCCCTCC CTTCCTCCCT TCCTTCCTTA 780
CTTCTTCCTT CCTTCCCTCC TTCCTTCCTA AATTAATAGA CCTTTTTTTA AAGAGCAATT 840
TTGGGTTTAC AGAAAAATTG AGTCATAAGT ACAGGGAGTT CTCATTGACC TCTCCGCACC 900
CTGCCACACA CGGTTTCTCC TATGGTTAAC CTGTTGCATT GGTGTGATAC ATCTGTTACA 960
ACTGACAAAC CAGTACTGAC ATGCTCTCAT TCGCTAAGGT CCCTCGTTCA CATCAGACTA 1020
CACTCTTGAT GGTGTACACT CTGTGGGTTT TGACGAATGC ATAATGACAT GTCTCCACCA 1080
TTACAGTAGC CTACAGAGCC TTTCACAGCC CAAAACATTC CTTGTGTCCT CCTACTCATT 1140
CCTCCCTCCT CCCAACCCCT TGCGACCACT GATCTTTTTA CTGTCTTTGT AGTTTTGCCT 1200
TTTCCAGAGT GTCGAATAGC TGCAAGCAAA CACACAGTAT GCAGCCTTTT CAGATCGGCT 1260
ACTTTCATCT AGCAATGTGG AGTTAGGGTT CCTCCAGGTC TTTTCACGGC TTGATAGCAC 1320
ATTCCTTTTT CTTGCTGAAC AATATTGTGT TGTATGGATG TACCAGTTCA TCTATTTCTG 1380
AAGGATATCT TGGTTTGTTC TGAATGTTTA GCAATGATGA ATAAAGCTGA CATAAACATT 1440
CATACGCAGT TTTTTTTATG GACAAAGTTT TCAACTCATT TGGGGAAATA CAGTATTTGT 1500
CTTTTTGTGG CTGGCTTATT TCATTTAGTG CAGTGTCCTC AACTTTCCTC CATGCTGTGG 1560
CATGTACCCT TTCTTTTCAA GGCTGATAAA AATTTCATTG TATATAAACA CACACCACTA 1620
GCTATTGACT GTTTTAATAT GAGCCTGCTT TCAATTCCTT TGGAGGTATT TCAAGAAGTG 1680
GGATTGCTGA ATCACAAGGT AATTCTATTT TTAATTTTTC AAAGACGCAC CATACTGTTT 1740
TTTCCACAGA GGCTTCACCA ACACTTGTTA TTTCCTTGTT CTTTTTTTTT TCTTTTAGTA 1800
GCTGTCTCAA TGGGTGTGAA ATGATATCTC ATTGCAGTTT TGACTTGCAT TTCCGTGATG 1860
ATGACTGATG ACATTGAGCA TCTTTTCACA TTCTTCTTGG CCATTTATAT ATCATCTTTG 1920
GAGAAATGTC TATTTAAGTC CTTTGTCCAT TTTAAAATCA CGTTGTTTTT TGTTGTTGTT 1980
GAGTTGTAGG 1990